Abstract:Abstract Background: Thyroid cancer (TC) account for 90% of endocrine malignant tumor. The association between thyroid inflammation and carcinogenesis has long been recognized. However, the differential immunological mechanisms underlying pathogenesis of papillary thyroid cancers (PTCs) and benign thyroid nodules (BTNs) have not been well characterized. In this study, we aimed to explore the immunological differences between PTCs and BTNs. Further, we attempted to develop a novel classifier based on DNA methylation of immune response genes for thyroid cancer precise diagnosis. Methods: A publicly available tissue Reduced Representative Bisulfite Sequencing dataset composed of 80 PTCs and 65 BTNs was collected (GSE107738), including a training cohort (39 PTCs, 28 BTNS) and a testing cohort (41 PTCs, 37 BTNs). We identified differentially methylated regions (DMRs) between PTCs and BTNs. Functional enrichment analyses of DMR-associated genes were conducted by hypergeometric test. DNA methylation markers of immune response genes were extracted. A diagnostic classifier based on these markers was developed using a training cohort and was validated in an independent testing cohort. These markers were further confirmed by two independent datasets (GSE53051: 20 PTCs, 32 BTNs; GSE97466: 60 PTCs, 17 BTNs) generated by the Infinium Methylation 450K array. A new classifier based on the corresponding 15 array-based methylation markers was built using these two datasets, and was validated in the 450K array data of 499 thyroid malignant tissue samples in the TCGA database. Results: We identified 220 DMRs between PTCs and BTNs. DMR-associated genes were significantly enriched in immune response biological processes. The classifier comprised of 15 DNA methylation markers from immune response genes achieved 100% sensitivity, 76% specificity, 82% positive predictive value (PPV), 100% negative predictive value (NPV) and 88% accuracy in the testing cohort. This classifier also demonstrated high accuracy for cytologically indeterminate thyroid nodules (25 PTCs, 29 BTNs). Leave-one-out cross validation using the corresponding array methylation markers in two independent datasets achieved prediction accuracy of 92% and 95%, respectively. An array-based classifier trained on all samples of the methylation array data achieved a sensitivity of 89% in classifying 499 thyroid malignant tissue samples in the TCGA database. Conclusion: Our study demonstrated that DNA methylation signature of immune response gene could be used to differentiate PTCs from BTNs with high accuracy, which may be caused by the different immunological microenvironments in response to PTCs and BTNs. Citation Format: Yiying Li, Minjie Xu, Jin Sun, Qiye He, Zhixi Su, Rui Liu. DNA methylation-based immune response signature for thyroid nodule diagnostics [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 6194.

Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study

Impairment of Regulatory Capacity of Cd4(+)Cd25(+) Regulatory T Cells Mediated by Dendritic Cell Polarization and Hyperthyroidism in Graves' Disease

DNA Methylation Patterns in the HLA-DPB1 and PDCD1LG2 Gene Regions in Patients with Autoimmune Thyroiditis from Different Water Iodine Areas.

Effects of Thyrostatic Treatment on T,B Lymphocytes and Expression of Costimulatory Molecules on Pripheral Blood Lymphocytes of Patients with Graves' Disease

DNA Methylation of KLRC1 and KLRC3 in Autoimmune Thyroiditis: Perspective of Different Water Iodine Exposure

Genome-wide DNA Methylation Pattern in Whole Blood of Patients with Hashimoto Thyroiditis.

Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves' disease

Effects of Different Iodine Levels on the DNA Methylation of Intrinsic Apoptosis-Associated Genes and Analysis of Gene-Environment Interactions in Patients with Autoimmune Thyroiditis

Aberrant Histone Methylation in Patients with Graves' Disease.

Absolute reduction in peripheral regulatory T cells in patients with Graves’ disease and post-treatment recovery

A Global Regulatory Network for Dysregulated Gene Expression and Abnormal Metabolic Signaling in Immune Cells in the Microenvironment of Graves’ Disease and Hashimoto’s Thyroiditis

Genome-wide DNA Methylation Analysis in Graves' Disease.

Effect of Different Iodine Levels on the DNA Methylation of PRKAA2, ITGA6, THEM4 and PRL Genes in PI3K-AKT Signaling Pathway and Population-Based Validation from Autoimmune Thyroiditis Patients

Distribution of Lymphocyte Subpopulations in Thyroid Glands of Human Autoimmune Thyroid Disease

Differential Microrna Expression in Peripheral Blood Mononuclear Cells from Graves' Disease Patients

Elevated Serum IL-16 and RANTES Levels in Patients with Autoimmune Thyroid Diseases and Modulation by Methimazole Therapy.

Abstract 6194: DNA methylation-based immune response signature for thyroid nodule diagnostics

Changes of the mRNA expression of TBX21, GATA3, RORC, FOXP3 before and after the treatment of Graves' hyperthyroidism and Graves' ophthalmopathy

Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia

The Whole Blood DNA Methylation of RAB8A and RAP1A in Autoimmune Thyroiditis: Evidence and Validation of Iodine Exposure in a Population from Different Water Iodine Areas.

Development of Thyroid Dysfunction and Autoantibodies in Graves' Multiplex Families: an Eight-Year Follow-Up Study in Chinese Han Pedigrees.